TVGNW · Tevogen Bio Holdings Inc.

Summary

Tevogen Bio Holdings Inc. filed a Certificate of Amendment effecting a 1-for-50 reverse stock split of its Common Stock, effective March 6, 2026, to reduce issued shares from 202,416,556 while maintaining 800,000,000 authorized shares. The split aims to regain Nasdaq compliance, with trading on a post-split basis under unchanged symbol TVGN and new CUSIP 88165K200; fractional shares settle in cash.

Key takeaways

• Reverse stock split at 1-for-50 ratio effective March 6, 2026 at 12:01 a.m. ET
• Filed Certificate of Amendment on March 3, 2026 with Delaware Secretary of State
• Pre-split: 202,416,556 Common Stock shares issued and outstanding as of March 3, 2026
• New CUSIP: 88165K200; trading symbol TVGN unchanged
• Stockholders approved on February 19, 2026, with Board discretion on ratio between 1-for-25 and 1-for-85
• No fractional shares issued; cash payment based on closing price day before Effective Date